Literature DB >> 10915934

Enhanced transdermal delivery of tetracaine by electroporation.

Q Hu1, W Liang, J Bao, Q Ping.   

Abstract

The effect of electroporation on the transport of tetracaine through skin in vitro was studied using side-by-side compartment diffusion cells method. After achieving steady state by passive diffusion, fluxes of tetracaine achieved with passive diffusion, electroporative pulse and iontophoresis were compared. Electroporation (square-wave pulse, voltage 130 V, pulse time 0.4 s, pulse frequency 40 pulses min(-1)) or iontophoresis (0.2.mA cm(-2), lasting for 4 h) increased the transport of tetracaine through skin. The flux of tetracaine at 0.25 h after electroporation (pulse number 400) was 54.6+/-6.0 microg.cm(-2).h(-1), that after iontophoresis was 17.4+/-5.8 microg.cm(-2).h(-1) and that after passive diffusion was 8.2+/-0.5 microg.cm(-2).h(-1). In addition, the fluxes of tetracaine increased with the increasing of pulse number. From these results, it is clear that electroporation is effective in enhancing transdermal delivery of tetracaine and its function is better than iontophoresis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915934     DOI: 10.1016/s0378-5173(00)00432-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers.

Authors:  Yuefeng Rao; Feiyue Zheng; Xingguo Zhang; Jianqing Gao; Wenquan Liang
Journal:  AAPS PharmSciTech       Date:  2008-07-23       Impact factor: 3.246

Review 2.  Perspectives on Transdermal Electroporation.

Authors:  Kevin Ita
Journal:  Pharmaceutics       Date:  2016-03-17       Impact factor: 6.321

3.  Enhancement strategies for transdermal drug delivery systems: current trends and applications.

Authors:  Delly Ramadon; Maeliosa T C McCrudden; Aaron J Courtenay; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2021-01-20       Impact factor: 4.617

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.